Company Overview:
Dr. Reddy’s Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Financial Results:
Dr. Reddy’s Laboratories reported Total revenue for Q4FY25 of ₹ 9,050 Crore up from ₹7,311 Crore in Q4FY24, a rise of 24% y-o-y.
Total Expense for Q4FY25 of ₹7,050 Crore up from ₹5,709 Crore in Q4FY24, a rise of 23% y-o-y.
Net Profit of ₹1,593 Crore up 22% from ₹1,310 Crore in Q4FY24.
Earnings per Share is ₹19.12, up 21% from ₹15.73 in Q4FY24.
![](data:image/svg+xml;charset=utf-8,<svg height="977px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
